Hybridoma technology steps are a series of entrenched methods to produce mAbs ( monoclonal antibodies) to antigens of interest. Hybridoma cell lines are formed by combining a short-lived antibody-producing B cell and an immortal myeloma cell. Every hybridoma constitutively conveys a considerable[…]
Read MoreRecently, FDA (Food and Drug Administration) has enlarged the potential application of mAb (monoclonal antibody) therapy for inhibitory use, which are at serious risk due to a confirmed exposure to the virus. The permission was based on a substantial clinical trial that[…]
Read MoreAntibodies, the Y shaped proteins, aka immunoglobulins (Igs), are produced by the plasma cells. These can identify the antigens that are foreign invaders or molecules as pathogens, toxins, and more. The Y shaped structure in the antibody is to locate and bind[…]
Read MoreB-cell And T-Cell Epitope Mapping With the antigen encounter, the host humoral immunity activates, which triggers the production of antibodies that are against the foreign invader protein epitopes. Immune system components recognise the epitope as antibodies, B cells and T cells. These[…]
Read MoreAt GeNext Genomics, we are highly proud to serve the industry with the ability to cater for clients with antibody engineering services. These constitute each format, from the antibody fragments to the humanized antibodies. scFv/Fab scFV/Fab construction is the first and foremost[…]
Read MoreAll through three-generation, we have witnessed the wonderful use of Monoclonal antibody production in the way it helps in our diagnosis and therapy. Immunotherapy with a targeted molecule like Antibody has gained a lot of attention in cancer treatment due to its[…]
Read MoreWhat are monoclonal antibodies (MABs)? Monoclonal antibodies are proteins produced in the laboratory that can bind to body cells, even cancer cells. There are different types of monoclonal antibodies, or MABs, designed to carry out specific functions. At the same time, a[…]
Read More